ClinicalTrials.gg
CompletedNCT05912920Updated Oct 15, 2026

Laparoscopic Natural Gastric Banding for Morbid Obesity

An interventional study of gastric band in Obesity, Morbid, sponsored by Minia University. Completed at 2 sites in Egypt. Open to participants aged 18 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Minia University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 15, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Obesity, Morbid by Minia University — none open to participants now, none under way, none of them phase 3. Obesity, Morbid · Minia University.

Enrollment
14th of 18
100 · median 150
Started
2023
the only one that year
No phase
17 of 18
none open now
Registered
16th of 18
by date

Among the 18 studies in Obesity, Morbid by Minia University, this one is the 14th largest by enrollment, is the only one that started in 2023, is one of 17 with no phase, and was the 16th registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

None of the 18 studies in Obesity, Morbid by Minia University is open now. The open studies under Obesity, Morbid, anywhere →

Where they have run

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 18 studies in Obesity, Morbid by Minia University as a file.
02

Study summary

to do gastric banding using round ligament or omental flap instead of synesthetic band

Read the detailed description

the round ligament or omental flap is used for gastric band instead of synesthetic band which had many complications that led to its abandon

03

Conditions studied

  • Obesity, Morbid

Browse trials for

04

Who can participate

Ages eligible
18 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • obese patients with more than 40 with or without co-morbidity or more than 35 with co-morbidity
  • patients fit for laparoscopic surgery
  • give approval to share in the study
  • previous restrictive bariatric procedure

Exclusion criteria

Exclusion Criteria:

  • patients unfit for surgery
  • patients aged less than 18 and older than 60
  • patient with previous upper abdominal surgery either for obesity or other diseases
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    gastric band

    to do gastric banding use either round ligament or omental flap

    Procedure: gastric band

  • Active comparator
    sleeve gastrectomy

    to do sleeve gastrectomy as standard

    Procedure: gastric band

Interventions

  • Proceduregastric band

    gastric band

06

What researchers measure

Primary outcomes

  1. %EWL

    percentage of excess weight loss at one year

    Time frame: 12 months

Secondary outcomes

  1. complications rate

    the incidence of complications

    Time frame: 12 months

07

Study locations

2 sites
  • Faculty of medicine
    Minya, 61511, Egypt
  • Minia university hospital
    Minya, 61511, Egypt
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2023 to primary completion in Jan 2025, 18 months.

Of 273 non-industry interventional studies with no phase under Obesity, Morbid, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 48. This study's 18 months is below that.

Counting every sponsor, half of 285 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Aug 2024 → Jan 2025 and completion Oct 2024 → Feb 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2023
First posted
Jun 22, 2023
StartActual
Jul 1, 2023
Primary completionActual
Jan 11, 2025was Aug 2024
CompletionActual
Feb 1, 2025was Oct 2024
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 15, 2026
Primary completion
Aug 1, 2024→Jan 11, 2025 (actual)
Oct 15, 2026
Study completion
Oct 1, 2024→Feb 1, 2025 (actual)
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Recruiting→Completed
    Primary completion Aug 1, 2024→Jan 11, 2025 (now actual)
    Study completion Oct 1, 2024→Feb 1, 2025 (now actual)
    + 4 other changes: verification date, site details, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT05912920
Lead sponsor
Minia University
Responsible party
Alaa Mstafa Hassan Sewefy (prof., Minia University) — Principal investigator
First posted
Jun 22, 2023
Start date
Jul 1, 2023
Primary completion
Jan 11, 2025
Completion
Feb 1, 2025
Last update
Oct 15, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion